Table 3  DGL5 113A variant allele frequency, carrier frequency, heterozygote frequency, and homozygote frequency in the inflammatory bowel disease, Crohn’s disease, ulcerative colitis, and control populations

	Controls	IBD (p value)	Crohn’s disease (p value)	Ulcerative colitis (p value)
Allelic frequency	13.2%	11.4% p = 0.30	11.4% p = 0.37	11.4% p = 0.34
Carrier frequency	63/256 (24.6%)	125/652 (19.2%) p = 0.069	65/356 (18.3%) p = 0.057	60/296 (20.3%) p = 0.228
Heterozygosity rates	59/256 (23%)	110/650 (16.7%) p = 0.033	57/356 (16%) p = 0.029	53/294 (18%) p = 0.45
Homozygosity rates	4/256 (1.5%)	15/650 (2.3%) p = 0.48	8/356 (2.2%) p = 0.36	7/294 (2.4%) p = 0.50
The p values shown are calculated between the control group and each respective disease group.